{"disease":{"id":"differentiated-thyroid-cancer","name":"differentiated thyroid cancer"},"drugs":{"marketed":[{"drug_id":"levoxyl","indication_name":"TSH suppression in thyrotropin-dependent well-differentiated thyroid cancer - adjunct to surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levoxyl","generic_name":"Levothyroxine Sodium","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Thyroid receptor proteins attached to DNA","drug_class":"Thyroid hormone replacement","quality_score":10,"revenue":null,"mechanism":"Levothyroxine binds thyroid receptors in cell nuclei to activate gene transcription and protein synthesis."},{"drug_id":"levoxyl","indication_name":"TSH suppression in thyrotropin-dependent well-differentiated thyroid cancer - adjunct to radioiodine therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levoxyl","generic_name":"Levothyroxine Sodium","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Thyroid receptor proteins attached to DNA","drug_class":"Thyroid hormone replacement","quality_score":10,"revenue":null,"mechanism":"Levothyroxine binds thyroid receptors in cell nuclei to activate gene transcription and protein synthesis."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04857086","title":"The Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China","phase":"","overall_status":"UNKNOWN","enrollment_count":1400,"lead_sponsor_name":"Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT03170960","title":"Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":914,"lead_sponsor_name":"Exelixis","has_results":false},{"nct_id":"NCT01837745","title":"Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":776,"lead_sponsor_name":"Gustave Roussy, Cancer Campus, Grand Paris","has_results":false},{"nct_id":"NCT07239674","title":"Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":646,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT06671184","title":"Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Shanghai 6th People's Hospital","has_results":false},{"nct_id":"NCT05604963","title":"Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers","phase":"NA","overall_status":"RECRUITING","enrollment_count":456,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT03757637","title":"Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":380,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT07229859","title":"Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening","phase":"","overall_status":"COMPLETED","enrollment_count":332,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT04500925","title":"The Incidence of Postoperative Re-stratification for Recurrence in Well-differentiated Thyroid Cancer - A Single Tertiary Israeli Center Experience","phase":"","overall_status":"COMPLETED","enrollment_count":301,"lead_sponsor_name":"Tel-Aviv Sourasky Medical Center","has_results":false},{"nct_id":"NCT05078853","title":"Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Soroka University Medical Center","has_results":false},{"nct_id":"NCT07259304","title":"Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT01876784","title":"Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":238,"lead_sponsor_name":"Genzyme, a Sanofi Company","has_results":true},{"nct_id":"NCT01843062","title":"Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":233,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT03794375","title":"Primary Care Transfer for Thyroid Cancer Patients","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":206,"lead_sponsor_name":"Hospital de Clinicas de Porto Alegre","has_results":false},{"nct_id":"NCT03602495","title":"A Phase 3 Study of Donafenib in Patients With Radioiodine-refractory Differentiated Thyroid Cancer","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":204,"lead_sponsor_name":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","has_results":false},{"nct_id":"NCT04971473","title":"Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","has_results":false},{"nct_id":"NCT03690388","title":"A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":187,"lead_sponsor_name":"Exelixis","has_results":true},{"nct_id":"NCT07115810","title":"No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort","phase":"","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"King Faisal Specialist Hospital & Research Center","has_results":false},{"nct_id":"NCT04940052","title":"Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":153,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT02966093","title":"A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":151,"lead_sponsor_name":"Eisai Co., Ltd.","has_results":false},{"nct_id":"NCT05538130","title":"A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":124,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT02432274","title":"Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"Eisai Limited","has_results":true},{"nct_id":"NCT04563780","title":"The Prognostic Value of Post Thyroidectomy 99mTCpertechnetate Thyroid Scan in Patient With Differentiated Thyroid Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":113,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07453225","title":"Empirical Radioactive Iodine Therapy in DTC","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06154863","title":"Recurrence in Patients With Differentiated Thyroid Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07068542","title":"Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":94,"lead_sponsor_name":"Zhejiang Provincial People's Hospital","has_results":false},{"nct_id":"NCT04522570","title":"Thermal Ablation of Cervical Metastases From Thyroid Carcinoma","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":84,"lead_sponsor_name":"Instituto do Cancer do Estado de São Paulo","has_results":false},{"nct_id":"NCT04420754","title":"Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":70,"lead_sponsor_name":"AffyImmune Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04137185","title":"Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","has_results":false},{"nct_id":"NCT05510934","title":"Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Nova Scotia Health Authority","has_results":false},{"nct_id":"NCT07436455","title":"F-18 Tetrafluoroborate PET/CT in Differentiated Thyroid Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Ankara University","has_results":false},{"nct_id":"NCT05299437","title":"Metastatic Thyroid Cancer Therapy Optimization With 124I PET Dosimetry","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Carlo Chiesa","has_results":false},{"nct_id":"NCT05789667","title":"Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Regina Elena Cancer Institute","has_results":false},{"nct_id":"NCT03176485","title":"Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors","phase":"NA","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"University of Arizona","has_results":false},{"nct_id":"NCT06647602","title":"Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT06970353","title":"Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07287748","title":"A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":38,"lead_sponsor_name":"Alpha Fusion Inc.","has_results":false},{"nct_id":"NCT05014698","title":"IDEntification of New Predisposition Genes in Differentiated THYroid Cancer","phase":"NA","overall_status":"TERMINATED","enrollment_count":34,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT07536412","title":"Decision Aid Efficacy in Low Risk Thyroid Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":34,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT05745363","title":"Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT05024929","title":"Targeted Therapy to Increase RAI Uptake in Metastatic DTC","phase":"","overall_status":"RECRUITING","enrollment_count":32,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT05989425","title":"Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":32,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT03449108","title":"LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06405217","title":"Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT04321954","title":"Lenvatinib in Locally Advanced Invasive Thyroid Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":false},{"nct_id":"NCT03986437","title":"A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection.","phase":"","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Institut Claudius Regaud","has_results":false},{"nct_id":"NCT05599139","title":"Iodine Uptake After a Low Iodine Diet","phase":"NA","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT04560127","title":"Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06898437","title":"Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT05007093","title":"Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Yansong Lin","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}